Health-Related Quality of Life in Patients with Oesophageal Cancer: Analysis at Different Steps of the Treatment Pathway

Journal of Gastrointestinal Surgery

Volumn 17, Issue 3, 2013, Pages 421-433

  Scarpa, Marco ^a   Saadeh, Luca M ^a   Fasolo, Alessandra ^a   Alfieri, Rita ^a   Cagol, Matteo ^a   Cavallin, Francesco ^a   Pinto, Eleonora ^a   Zaninotto, Giovanni ^b,c   Ancona, Ermanno ^a,c   Castoro, Carlo ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b Divisione Medica I   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Health related quality of life; Oesophageal cancer

Indexed keywords

EID: 84873749641     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-012-2069-1     Document Type: Article

References (38)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003 Jan-Feb; 53(1): 5-26.
2. Ruol A, Castoro C, Portale G, Cavallin F, Sileni VC, Cagol M, Alfieri R, Corti L, Boso C, Zaninotto G, Peracchia A, Ancona E. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution. Arch Surg. 2009 Mar; 144(3): 247-54.
3. De Vita F, Di Martino N, Orditura M, Cosenza A, Galizia G, Del Genio A, Catalano G. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study. Chest 2002; 122: 1302-1308.
4. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003 Dec 4; 349(23): 2241-52.
5. Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003; 4: 481-488.
6. Jamieson GG, Mathew G, Ludemann R, Wayman J, Myers JC, Devitt PG. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004; 91: 943-947.
7. Viklund P, Lindblad M, Lu M, Ye W, Johansson J, Lagergren J. Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg 2006; 243(2): 204-11.
8. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J; Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007 Mar; 8(3): 226-34.
9. Greer SE, Goodney PP, Sutton JE, Birkmeyer JD. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery. 2005 Feb; 137(2): 172-7.
10. Zacherl J, Sendler A, Stein HJ, Ott K, Feith M, Jakesz R, Siewert JR, Fink U. Current status of neoadjuvant therapy for adenocarcinoma of the distal esophagus. World J Surg. 2003 Sep; 27(9): 1067-74.
11. Brücher BL, Stein HJ, Zimmermann F, Werner M, Sarbia M, Busch R, Dittler HJ, Molls M, Fink U, Siewert JR. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol. 2004 Nov; 30(9): 963-71.
12. McLeod RS. Quality-of-life measurement in the assessment of surgical outcome. Adv Surg. 1999; 33: 293-309.
13. Scarpa M, Valente S, Alfieri R, Cagol M, Diamantis G, Ancona E, Castoro C. Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol. 2011 Nov 14; 17(42): 4660-74.
14. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug; 240(2): 205-13.
15. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
16. Apolone G, Filiberti A, Cifani S, Ruggiata R, Mosconi P. Evaluation of the EoRTC QLQ C30 questionnaire: a comparison with SF36 Health Survey in a cohort of Italian long survival cancer patients. Ann Oncol 1998; 9(5): 549-557.
17. Blazeby JM, Conroy T, Hammerlid E, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39: 1384-1394, 2003.
18. Bredart A, Bottomley A, Blazeby J for the EORTC QOL study group. An international prospective study of the psychometric properties of the EORTC IN-PATSAT32 in assessing cancer patient perception of the quality of care received in the hospital. Eur J Cancer 2005; 41: 2120-31.
19. Bredart A., Coens C., Aaronson N., Chie WC., Efficace F., Conroy T., Blazeby J. M., Hammerlid E., Costantini M., Joly F., Schraub S., Sezerl O., Arraras J. I., Rodary C., Costantini A., Mehlitz M., Razavi D., Bottomley A., on behalf of the EORTC Quality of Life Group and the EORTC Quality of Life Unit Determinants of patient satisfaction in oncology settings from European and Asian countries: Preliminary results based on the EORTC IN-PATSAT32 questionnaire Eur J Cancer 43 (2007) 323-330.
20. th ed. Springer 2009.
21. Ruol A, Portale G, Castoro C, Merigliano S, Cavallin F, Battaglia G, Michieletto S, Ancona E. Management of esophageal cancer in patients aged over 80 years. Eur J Cardiothorac Surg. 2007 Sep; 32(3): 445-8.
22. Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer. 2001 Jun 1; 91(11): 2165-74.
23. Brunelli C, Mosconi P, Boeri P, Gangeri L, Pizzetti P, Cerrai F, Schicchi A, Apolone G, Tamburini M. Evaluation of quality of life in patients with malignant dysphagia. Tumori. 2000 Mar-Apr; 86(2): 134-8.
24. Levenstein S, Li Z, Almer S, Barbosa A, Marquis P, Moser G, Sperber A, Toner B, Drossman DA. Cross-cultural variation in disease-related concerns amongpatients with inflammatory bowel disease. Am J Gastroenterol. 2001Jun; 96(6): 1822-30.
25. Barbour AP, Lagergren P, Hughes R, Alderson D, Barham CP, Blazeby JM Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg. 2008 Jan; 95(1): 80-4.
26. Egberts JH, Schniewind B, Bestmann B, Schafmayer C, Egberts F, Faendrich F, Kuechler T, Tepel J. Impact of the site of anastomosis after oncologic esophagectomy on quality of life-a prospective, longitudinal outcome study. Ann Surg Oncol. 2008 Feb; 15(2): 566-75.
27. Lagergren P, Avery KN, Hughes R, Barham CP, Alderson D, Falk SJ, Blazeby JM. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer. 2007 Aug 1; 110(3): 686-93.
28. Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg. 2006 Sep; 93(9): 1084-90.
29. Avery KN, Metcalfe C, Barham CP, Alderson D, Falk SJ, Blazeby JM. Quality of life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg. 2007 Nov; 94(11): 1369-76.
30. van Meerten E, van der Gaast A, Looman CW, Tilanus HW, Muller K, Essink-Bot ML. Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2008 May 1; 71(1): 160-6. Epub 2007 Dec 31.
31. Viklund P, Lindblad M, Lagergren J. Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection. World J Surg. 2005 Jul; 29(7): 841-8.
32. Rutegård M, Lagergren J, Rouvelas I, Lindblad M, Blazeby JM, Lagergren P. Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. Br J Surg. 2008 May; 95(5): 592-601.
33. Brodner G, Pogatzki E, van Aken H, Buerkle H, Goeters C, Schulzki C, Nottberg H, Mertes N. A multimodal approach to control postoperative pathophysiology and rehabilitation in patients undergoing abdominothoracic esophagectomy. AnesthAnalg. 1998 Feb; 86(2): 228-34.
34. Ali M, Winter DC, Hanly AM, O'Hagan C, Keaveny J, Broe P. Prospective, randomized, controlled trial of thoracic epidural or patient-controlled opiate analgesia on perioperative quality of life. Br J Anaesth. 2010 Mar; 104(3): 292-7.
35. Ariga H, Nemoto K, Miyazaki S, Yoshioka T, Ogawa Y, Sakayauchi T, Jingu K, Miyata G, Onodera K, Ichikawa H, Kamei T, Kato S, Ishioka C, Satomi S, Yamada S. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2009; 75: 348-356.
36. Leibman S, Smithers BM, Gotley DC, Martin I, Thomas J Minimally invasive esophagectomy: short- and long-term outcomes. Surg Endosc. 2006 Mar; 20(3): 428-33. Epub 2005 Dec 28.
37. Wang H, Feng M, Tan L, Wang Q. Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery. Dis Esophagus 2010; 23: 408-414.
38. McLeod RS, Churchill DN, Lock AM. Quality of life of patients withulcerative colitis preoperatively and postoperatively. Gastroenterology. 1991; 101: 1307-1313.